151 related articles for article (PubMed ID: 12170133)
21. Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.
Ohana B; Lipson M; Vered N; Srugo I; Ahdut M; Morag A
Clin Diagn Lab Immunol; 2000 Nov; 7(6):904-8. PubMed ID: 11063496
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
Eing BR; Lippelt L; Lorentzen EU; Hafezi W; Schlumberger W; Steinhagen K; Kühn JE
J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950
[TBL] [Abstract][Full Text] [Related]
23. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a near-patient test and 2 enzyme-linked immunosorbent assay-based assays for detecting anti-herpes simplex virus type-2 antibodies.
Palù G; Calistri A; Cancellotti E; Cusan M; Mengoli C;
Scand J Infect Dis; 2001; 33(10):794-6. PubMed ID: 11728057
[TBL] [Abstract][Full Text] [Related]
26. Herpes serology for dermatologists.
Goldman BD
Arch Dermatol; 2000 Sep; 136(9):1158-61. PubMed ID: 10987876
[TBL] [Abstract][Full Text] [Related]
27. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection.
Cowan FM; Johnson AM; Ashley R; Corey L; Mindel A
J Infect Dis; 1996 Sep; 174(3):470-5. PubMed ID: 8769602
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses.
Van Doornum GJ; Slomka MJ; Buimer M; Groen J; Van den Hoek JA; Cairo I; Vyse A; Brown DW
Clin Diagn Lab Immunol; 2000 Jul; 7(4):641-4. PubMed ID: 10882665
[TBL] [Abstract][Full Text] [Related]
29. Availability of serologic and virologic testing for herpes simplex virus in the largest sexually transmitted disease clinics in the United States.
Warren T; Gilbert L; Mark H
Sex Transm Dis; 2011 Apr; 38(4):267-9. PubMed ID: 21139516
[TBL] [Abstract][Full Text] [Related]
30. Underestimation of HSV-2 seroprevalence in a high-risk population by microneutralization assay.
Ashley RL; Dalessio J; Dragavon J; Koutsky LA; Lee FK; Nahmias AJ; Stevens CE; Holmes KK; Corey L
Sex Transm Dis; 1993; 20(4):230-5. PubMed ID: 8211541
[TBL] [Abstract][Full Text] [Related]
31. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma.
Groen J; Hersmus B; Niesters HG; Roest W; van Dijk G; van der Meijden W; Osterhaus AD
J Clin Virol; 1999 May; 12(3):193-200. PubMed ID: 10382816
[TBL] [Abstract][Full Text] [Related]
33. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.
Austin H; Macaluso M; Nahmias A; Lee FK; Kelaghan J; Fleenor M; Hook EW
Sex Transm Dis; 1999 Jul; 26(6):329-34. PubMed ID: 10417020
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection.
Philip SS; Ahrens K; Shayevich C; de la Roca R; Williams M; Wilson D; Bernstein K; Klausner JD
Clin Infect Dis; 2008 Nov; 47(10):e79-82. PubMed ID: 18840082
[TBL] [Abstract][Full Text] [Related]
35. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
[TBL] [Abstract][Full Text] [Related]
36. Serological profile of HSV-2 in patients attending STI clinic: evaluation of diagnostic utility of HSV-2 IgM detection.
Choudhry S; Ramachandran VG; Das S; Bhattacharya SN; Mogha NS
Indian J Pathol Microbiol; 2009; 52(3):353-6. PubMed ID: 19679959
[TBL] [Abstract][Full Text] [Related]
37. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
Wald A; Ashley-Morrow R
Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
[TBL] [Abstract][Full Text] [Related]
38. Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population.
Aldisi RS; Elsidiq MS; Dargham SR; Sahara AS; Al-Absi ES; Nofal MY; Mohammed LI; Abu-Raddad LJ; Nasrallah GK
J Clin Virol; 2018 Jun; 103():1-7. PubMed ID: 29597097
[TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus type 2 seroepidemiology in Spain: prevalence and seroconversion rate among sexually transmitted disease clinic attendees.
Varela JA; García-Corbeira P; Agüanell MV; Boceta R; Ballesteros J; Aguilar L; Vázquez-Valdés F; Dal-ré R
Sex Transm Dis; 2001 Jan; 28(1):47-50. PubMed ID: 11196047
[TBL] [Abstract][Full Text] [Related]
40. Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.
Wales SQ; Smith CC; Wachsman M; Calton G; Aurelian L
Clin Diagn Lab Immunol; 2004 Jan; 11(1):42-9. PubMed ID: 14715543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
